Introduction
Erythropoietin (EPO) exerts its function through the speci®c membrane receptor (EPOR) which regulates the survival, proliferation, and dierentiation of erythroid progenitor cells (Todokoro et al., 1988) . Stimulation of EPOR by EPO induces tyrosine phosphorylation of EPOR as well as numerous cytoplasmic proteins, including a receptor-associated protein tyrosine kinase Jak2 (Witthuhn et al., 1993b) , phosphatidylinositol-3-kinase (PI3K) (Damen et al., 1993) , protein tyrosine phosphatases SHP-1 (Klingmuller et al., 1995) and SHP-2 (Klingmuller 1997; Sharlow et al., 1997) , and adapter proteins SHC and Grb2 (Miura et al., 1994; Damen et al., 1993a; He et al., 1995) . Transient activation of Jak/ STAT pathway as well as Ras/MAP kinase (MAPK) pathways after EPO-stimulation has been documented (Miura et al., 1994; Sawyer and Penta, 1996; Quelle et al., 1996; Torti et al., 1992; Todokoro et al., 1994; Tilbrook et al., 1996; Gobert et al., 1995; Nagata et al., 1997) . Among various EPO-dependent cell lines, good correlation has been observed between the basal activity of these signaling pathways and the proliferative potential of the cells (Gobert et al., 1995; Tilbrook et al., 1996; Miura et al., 1994; Carroll and May, 1994; Muszynski et al., 1998) .
Despite the abundant information on biochemical changes evoked by EPO, exactly how these signaling pathways aect erythroid dierentiation remains unclear. In erythroblasts prepared from experimentally induced anemic mice, dierentiation and proliferation seem to be inseparable from each other. Only recently, however, studies in vitro and in vivo begin to delineate the roles of speci®c signaling molecules in these processes. For instance, a dominant-negative STAT5 mutant was found to block the erythroid dierentiation induced by EPO (Iwatsuki et al., 1997; Wakao et al., 1997) . Conversely, forced expression of protein tyrosine phosphatase b2 gene was found to induce dierentiation in murine erythroleukemia cells (Kume et al., 1996) . In addition, Jak2-de®cient mice were found to have defects in de®nitive erythropoiesis which lead to embryonic death due to anemia (Parganas et al., 1998; Neubauer et al., 1998) .
In this study, we have investigated the role of Rassignaling pathway in erythroid dierentiation of SKT6 cell line. SKT6 was originally established from a splenic lesion of a DBA/2 mouse infected with the anemic strain of Friend murine leukemia virus complex (FVa) (Todokoro et al., 1987) . This cell line is capable of undergoing erythroid dierentiation at high eciency upon exposure to EPO (Kuramochi et al., 1990 (Kuramochi et al., , 1991 Sharlow et al., 1997) . Since EPO shows little eects on its proliferation, SKT6 cell line may provide a good model for the studies on the mechanism of EPO-induced erythroid dierentiation.
The Ras family proteins are known to transduce signals through a series of target molecules including two cytoplasmic protein serine/threonine kinases, Raf-1 and PI3K (Campbell et al., 1998) . Binding to the plasma membrane-associated Ras proteins enables Raf-1 kinase to phosphorylate its substrate MEK (a MAPK kinase) which in turn phosphorylates the 42/ 44-KDa species of MAPK (ERK). This phosphorylation allows ERK to translocate into the nucleus and to modify gene expression by phosphorylating certain transcription factors (Fukuda et al., 1997) . Other MAPKs, such as c-Jun N-terminal kinase (JNK) and p38MAPK (p38), may also be involved in the downstream signaling from Ras (Lin et al., 1995) . On the other hand, P13K activates other protein kinases, such as AKT and BTK, by generating phospholipid activators for these enzymes (Franke et al., 1997; Uckun, 1998) . Our experiments using gene transfer and pharmacological inhibitors suggest that persistent activities of Ras and its down-stream ERK pathway may be important for the suppression of erythroid dierentiation and maintenance of proliferative potential in SKT6 cell line.
Results
Expression of dominant-negative ras mutant (ras17N) and constitutively active ras mutant (ras12V) in SKT6 cells using Tet-regulation system SKT6 cells can be induced to dierentiate with 10 units/ml EPO or 1% DMSO (Watanabe et al., 1992; Kuramochi et al., 1990) . Using this cell line, we established two subclones which express either an activated (12V) or a dominant-negative (17N) mutant of H-ras oncogene (Feig and Cooper, 1988; Campbell et al., 1998) by using a tetracycline (Tet)-regulated expression system (Tet-o system) (Gossen and Bujard, 1992; Shockett et al., 1995) . In these clones (named ras17N/SKTtet and ras12V/SKTtet, respectively), strong induction of the transgene expression was observed both at the levels of mRNA and protein after withdrawal of Tet from the medium (Figure 1a ). In the presence of Tet (i.e. ras gene o), these clones did not signi®cantly dier from the control line (SKTtet) in their morphology and growth rates.
Effects of ras mutants on erythroid differentiation of SKT6 cells
Next we tried to detect the eects of ras transgene expression by determining the proportion of dierentiated cells after incubation of these cell lines in the presence or absence of EPO (Figure 1b) . The dierentiation can be conveniently assessed by staining the cells with 2,7-diamino¯uorene (2, 7-DAF) to detect hemoglobin synthesis (Johnson et al., 1993) . First of all, the control SKTtet cells responded to EPO in similar ways in the presence and absence of Tet (Figure 1b , compare bars 1, 2 and 3, 4), indicating that Tet itself did not interfere with the dierentiation-inducing activity of EPO. Likewise, all the cell lines responded to EPO in similar ways when the expression of transgenes were turned o with Tet ( Figure 1b , compare bars 1, 2; 5, 6; and 9, 10). Thus, all these cell lines retained the potential to dierentiate in response to EPO.
After induction of the activated ras12V mutant, however, strong suppression of both spontaneous and EPO-induced dierentiation was observed (Figure 1b , bars 7 and 8). Trypan blue-staining of the cells revealed no signs of increased cell death after ras12V expression (data not shown). These observations indicate that Ras-signal negatively regulates erythroid dierentiation in this system.
To our surprise, expression of the dominant negative ras17N mutant alone was sucient to increase 2,7-DAF-positive population (Figure 1b, bar 11, Figure 2) . The dierentiation could also be demonstrated by the increase in the level of b-globin mRNA and in the extent of staining with erythroid cell-speci®c monoclonal antibody, TER-119 (Ikuta et al., 1990; Aisaki et al., 1999) (Figure 3 ).
Behaviors of MAPKs after ras17N-expression in SKT6 cells
Since MAPK cascades are known to function downstream of Ras in various systems (Campbell et al., 1998) , we examined whether MAPK activities are (Marshall, 1995) have established that activation of ERK occurs through the phosphorylation of its threonine (Thr-202) and tyrosine (Tyr-204) residues by MEK in response to upstream signals. We therefore performed immunoblot assays with two antibodies, one speci®c to ERK and the other speci®c to phosphorylated ERK, to analyse its activation pro®le ( Figure 4a ). Phosphorylated ERK was dramatically reduced as early as 1 day after Tet-withdrawal, suggesting that Ras17N protein rapidly inactivated its downstream signal. We also analysed the phosphorylation pro®les of another member of the MAPK family, p38, which was recently found to be activated transiently in response to EPO (Nagata et al., 1997) . Activation of p38 is known to occur through phosphorylation of threonine-180 and tyrosine-182 (Raingeaud et al., 1995) , and this can also be monitored by similar immunoblot assay. In the ras17N-expressing cells, however, only gradual decrease in the levels of total p38 protein as well as its phosphorylated form was observed ( Figure 4b ). In similar immunoblot analysis, phosphorylated JNK was undetectable before and after ras17N-expression, while clear signals were detected in the control cells irradiated with UV, a stimulus known to activate this pathway ( Figure 4c ). Thus, the rapid decrease in unphosphorylated form of ERK was the most prominent changes we observed.
MEK inhibitor PD98059 induces erythroid differentiation in SKT6 cells
The above results raised the possibility that the erythroid dierentiation in SKT6 cells might be suppressed by the basal activity of Ras/ERK-signaling pathway. Consistent with this hypothesis, a speci®c (Dudley et al., 1995; Dumont et al., 1998; Lu et al., 1998; Kirken et al., 1997) , was found to induce erythroid dierentiation in dose-dependent manners not only in SKT6 cells but also in two other Friend leukemia-derived cell lines, TL200 and 1-2 (Figure 5a ,b,c). In these experiments, growth-suppressing eects of the drug became evident at the concentrations eective in inducing dierentiation. These biological responses were in good agreement with the degree of ERK-inactivation observed after 12 h treatment in SKT6 cells (Figure 5a,d) .
On the other hand, wortmannin (Kimura et al., 1994; Damen et al., 1995; Kirken et al., 1997) , an inhibitor of PI3K, did not induce dierentiation even at the concentrations that suppress cell growth to a comparable degree (Figure 5e ), suggesting that growthsuppression alone was not sucient for inducing dierentiation. This ®nding also suggests that PI3K, a key component of another signaling pathway downstream of Ras, does not play a major role in the Rasmediated inhibition of erythroid dierentiation observed in this system. No signs of increased cell death were detected by trypan blue-staining in the cultures treated with these inhibitors (data not shown), suggesting that selective killing of dierentiated or undierentiated cells does not account for these results. Nagata et al. (1998 Nagata et al. ( , 1999 have proposed a critical role for the activation of p38 and JNK in the dierentiation of SKT6 cells after various stimuli. The ras17N-induced dierentiation, however, is probably independent from such pathway, since a speci®c p38-inhibitor, SB203580, failed to inhibit this eect at concentrations where it strongly inhibited EPO-induced dierentiation (Figure 5f ).
Down-regulation of the ERK pathway during EPO-or DMSO-induced erythroid differentiation
Since our ®ndings suggested that ras17N (or PD98059) induce dierentiation by down-regulating ERK-phosphorylation, we attempted to test the possibility that EPO, a natural inducer of erythroid dierentiation, may also down-regulate this pathway. Consistent with this prediction, ERK phosphorylation was signi®cantly decreased after 2 day treatment with EPO ( Figure 6,  lanes 1, 2) . Even more dramatic decrease in ERKphosphorylation was observed when another erythroleukemia cell line, 1 ± 2, was treated with its ecient dierentiation inducer, DMSO ( Figure 6, lanes 3, 4) .
If the down-regulation of ERK pathway is indeed required for erythroid dierentiation, then constitutive activation of ERK should perturb this process. To test this prediction, we established a subline of SKTtet carrying a constitutively active MEK mutant, MAPKK LA-SDSE (MAPKKm) (Fukuda et al., 1997) , under the control of Tet-regulatable promoter. Upon removal of Tet from the medium, this cell line started to express high levels of the MAPKKm mRNA and protein (Figure 7a ). When the control SKTtet cells were treated with EPO, the levels of phosphorylated ERK were signi®cantly reduced both in the presence and absence of Tet (Figure 7b, lanes 3, 4; 1, 2) , excluding the possibility that Tet directly aects the levels of phosphorylated ERK. Similar down-regulation of phosphorylated ERK was observed when MAPKKm/ SKTtet cells were treated with EPO in the presence of Tet (MAPKKm gene o) (Figure 7b, lanes 7, 8) , although the extent of down-regulation was somehow milder. In contrast, when MAPKKm was switched on by removal of Tet from the medium, EPO-induced down-regulation of phosphorylated ERK did not occur (Figure 7b, lanes 5, 6) . Thus, the activation of ERK occurs as we expected in these cell lines.
We then monitored the dierentiation of MAPKKm/SKTtet cells after treatment with Tet and/ or EPO (Figure 7) . First of all, this cell line showed relatively low frequency of spontaneous dierentiation even in the presence of Tet (transgene o) (compare Figure 7c , bar 1 to Figure 1b , bar 1). After treatment with EPO, low but signi®cant increase in the proportion of dierentiated cells was observed ( Figure  7c , bar 2). This low frequency of dierentiation might be attributable to the limited extent of down-regulation of phosphorylated ERK mentioned above (Figure 7b , lane 8). When the mutant MEK gene (MAPKKm) was induced, both spontaneous and EPO-induced dierentiation were strongly inhibited (Figure 7c, bars 3, 4) . Moreover, both MAPKKm and ras12V signi®cantly inhibited the dierentiation of SKT6 cells induced by another inducer DMSO (Figure 7d ). The eects of another potent dierentiation inducer, n-butyrate, were also inhibited by expression of these constitutively No signi®cant growth inhibitory eects were observed with up to 10 mM of SB203580, and growth inhibition became obvious (50 ± 75% of control) at 20 mM. In this experiment, DMSO content was adjusted to 0.1% in all the dishes including control (0 mM). Bars represent mean+ s.e. from three dishes. All the experiments were repeated at least twice with similar results active transgenes (data not shown). These data support the hypothesis that inactivation of ERK-signaling is necessary, and probably sucient, for the initiation of erythroid dierentiation in SKT6 cells.
Discussion
In this study, we found that inhibition of basal Ras activity or ERK activity is sucient to induce 2,7-DAF-positive SKT6 cells (Figure 2 ) which, we assume, represent a step toward erythroid dierentiation. These ®ndings imply that basal activity of Ras/ERK signaling pathway plays a major role in preventing dierentiation and sustaining proliferative potential of these cells. Muszynski et al. (1998) recently reported that Friend murine leukemia virus (FV) may elevate the basal activity of Raf-1/MAPK pathway in infected cells, which oers an interesting hypothesis on the molecular mechanism of leukemogenesis by this virus. Consistent with this hypothesis, we observed that super-activation of Ras/ERK signaling pathway, through expression of Ras12V or MAPKKm, prevented the dierentiation induced by EPO, DMSO, or n-butyrate. These ®ndings suggest that an important common role for these exogenous dierentiation inducers may be to downregulate this pathway. At ®rst site, this hypothesis may seem inconsistent with the previous observations by others that EPO activates Ras/MAPK-signaling pathways. In previous studies, however, only the early activation of these pathways (up to 2 h) has been considered. For instance, Nagata et al. (1998 Nagata et al. ( , 1999 have shown that the transient activation of p38 and JNK, rather than ERK, is important for EPO-induced dierentiation in SKT6 cells. In the present study, we detected the down-regulation of ERK, which became apparent from day 2 after the addition of EPO (Figure 6; Figure 7b , lanes 1 ± 4). In the case of Ras17N-expression, ERK down-regulation was observed from day 1 (Figure 4a ), and this is consistent with the earlier onset of Ras17N-induced dierentiation as compared to the EPOinduced dierentiation. Thus, what we describe here represents persistent, rather than transient, eects of EPO-treatment and this could be more relevant to the erythroid dierentiation, which takes days to proceed. In addition, although the work by Nagata et al. (1998 Nagata et al. ( , 1999 convincingly disproved the role of early ERKactivation in EPO-induced dierentiation, they did not address the question of whether the basal ERK activity play any inhibitory role in dierentiation. Thus, taken together, these two studies might have revealed the possible counteraction between these multiple MAPK pathways during erythroid dierentiation. It should be emphasized, however, that the physiological relevance of these ®ndings with SKT6 cells to the normal erythroid dierentiation in vivo remains to be established in further studies. In fact, in a human chronic myelogenous leukemia cell line K562 which carries Philadelphia (BCR ± ABL) translocation, exogenous introduction of an activated ras gene was found to induce, rather than inhibit, erythroid dierentiation (Kang et al., 1999) , suggesting that the contribution of certain signaling molecule can be quite dierent depending on genetic make-up of the cells under study.
We and others previously reported that phosphorylation of Jak2 and STAT5 was induced after EPOstimulation in erythroblastoid cells (Yamamura et al., 1998) and in SKT6 cells (Sharlow et al., 1997) . There is also good evidence suggesting essential role for Jak2-STAT5 pathway in erythropoiesis in vitro and in vivo (Wakao et al., 1997; Iwatsuki et al., 1997; Parganas et al. 1998; Neubauer et al., 1998) . Our preliminary experiments, however, indicated that none of the transgenes used in this study (ras12V, ras17N, and MAPKKm) induced signi®cant alterations in the basal or EPO-induced phosphorylation of endogenous Jak2 protein nor did the ras17N gene aect the DNAbinding activity of endogenous STAT5 protein (our unpublished observation). Despite this, these transgenes had strong impact on cell dierentiation. These results raise the possibility that down-regulation of Ras-pathway is an event either down-stream of or independent from Jak2-STAT5 activation and both events may be essential for EPO-dependent erythropoiesis. Further studies to examine the interaction between these and other signaling pathways may yield important insights into the molecular basis for the regulation of cell growth and dierentiation in hematopoietic cells.
Materials and methods

Cell culture
Friend erythroleukemia-derived cell lines, SKT6 (Todokoro et al., 1987) , TG-gp55-1-2 (1-2) (Xu et al., 1995; Kato et al., 1997) , and TL200 (derived from the spleen from a DDD mouse infected with the anemic strain of Friend leukemia virus; N Imai and Y Ikawa, presented at the 1979 Japanese Cancer Association Meeting), were maintained in RPMI1640 medium containing 10% FCS and 20 mM 2-mercaptoethanol (GM). SKTtet cells were maintained in GM supplemented with 2 mg/ml tetracycline (Tet). ras 12 V/SKTtet, ras17N/ SKTtet, and MAPKKm/SKTtet cells were maintained in GM supplemented with 2.5 mg/ml Tet and 0.5 mg/ml G418 (Geneticin, Sigma). To induce transgene expression, the medium was switched to GM. To induce dierentiation, cells were inoculated at the density of 2610 4 cells/ml in GM containing 10 unit/ml human recombinant erythropoietin (EPO) or 1% dimethylsulfoxide (DMSO). Hemoglobinpositive cells were scored (usually on day 3) by staining with 0.5% 2,7-diamino¯uorene (2,7-DAF) (Johnson et al., 1993) . Stocks of inhibitors were made as follows and stored at 7208C: PD98059 (New England Biolabs), 50 mM in DMSO; SB203580 (Calbiochem), 20 mM in DMSO; wortmannin (Sigma), 1 mM in water.
Plasmids and transfection
The Tet-Regulated Expression System comprising of pTettTAk, pTet-Splice, and pUHC13-3 was obtained from Life Technologies. To construct inducible vectors, the 0.9 kb EcoRI ± NotI fragment encoding either human-H-Ras17N or human-H-Ras 12 V protein (Gift from Dr H Kitayama, Kyoto University), or the 1.2 kb BglII ± BglII fragment encoding Xenopus-LA-SDSE-MAPKK (Fukuda et al., 1997) was inserted into the EcoRV site of pTet-Splice vector. SKT6 cells ( 4610 6 ) were co-transfected with 3 mg of pTet-tTAk DNA together with 0.3 mg of pSV2bsr DNA (Kaken) using LipofectAMINE (Life Technologies, Inc.) in the presence of 2 mg/ml Tet. From 48 h later, the cells were selected in GM containing 12 mg/ml blasticidin-S. Fifteen days later, six transfectant clones were isolated. These clones were transiently transfected with luciferase-encoding pUHC13-3 vector, incubated in the presence and absence of Tet, and subjected to luciferase assay (Promega). One clone (named SKTtet) supporting about 100-fold induction of luciferase activity upon Tet removal was obtained. One of the pTet-Splice . human-H-ras17N , human-H-ras 12 V, or Xenopus-LA-SDSE-MAPKK) (1.3 mg) and pSRaneo (0.2 mg) were co-transfected into SKTtet cells in the presence of Tet (5 mg/ml), and from 48 h later, the transfectants were selected with medium containing Tet (5 mg/ml) and G418 (1 mg/ml ®nal). Clones were isolated, and the inducibility of the transgenes analysed by RNA blot hybridization and immuno-blot assay.
Immuno-blot assay
Boiled total cell lysates were resolved by SDS ± PAGE (10 or 12% polyacrylamide) and transferred electrophoretically onto a polyvinylidene di¯uoride (PVDF) membrane. The membranes were incubated with one of the following primary antibodies: anti-RAS (Funakoshi, NI-0038-30), a rabbit antiXenopus-MAPKK antiserum (a gift from Dr Eisuke Nishida), phospho-speci®c anti-ERK (Thr202/Tyr204) (NEB, #9101), phospho-speci®c anti-p38 (Thr180/Tyr182) (NEB, #9211), or phospho-speci®c anti-JNK/SAPK (NEB, #9251). After incubation with an appropriate secondary antibody, the immuno-reaction was detected by either BCIP/NBT Phosphatase Substrate System (Figures 1a, 7a , lower panels; and 4c) or enhanced chemiluminescence method (Amersham) on Image Reader LAS-1000 (FUJIFILM). In some experiments, the ®rst antibody was striped o and the same blot was reprobed with one of the following antibodies: anti-ERK (NEB, #9102) (Figures 4a, 5d ), anti-ERK1 (k-23) (Santa Cruz, #sc-094) (Figures 6, 7b) , anti-p38MAPK (NEB, #9212), or anti-JNK2 (FL) (Santa Cruz, (Figure 4c) . Note that the two anti-ERK antibodies gave slightly dierent results: #9102 detected only the lower band (p42) while #sc-094 detected two bands (p44 and p42).
RNA blot hybridization
Total RNA was extracted from cells by using RNasey Kit (QIAGEN). Eight micrograms of RNA was subjected to formalin-agarose gel electrophoresis (1% agarose), transferred onto nitrocellulose ®lter, and hybridized with 32 Plabeled probes. The ®lters were washed (®nal stringency: 0.16SSC, 0.1% SDS, 608C) and speci®c hybridization was detected using Image Analyzer BAS-2000 (Fuji Photo Film) . After removal of the ®rst probe by heating, the same blot was rehybridized with GAPDH or b-actin probe (Clontech).
